Skip to main content
. 2024 May 27;15:3822. doi: 10.1038/s41467-024-47745-z

Fig. 2. Risk of serious outcomes following SARS-CoV-2 infection prior to vaccination in children aged 5–11 years.

Fig. 2

Estimated number of excess events per million (95% CI) based on incidence rate ratios of each outcome in the 1–42 days following SARS-CoV-2 positive test compared to baseline period are presented where there were at least five events during the exposure period and when number of excess events is greater than zero. Data available from 8th December 2020 and 7th August 2022. Table 3 contains the data presented in this figure. MIS-C Multisystem inflammatory syndrome, ITP Idiopathic or immune thrombocytopenic purpura, ADEM Acute disseminated encephalomyelitis.